Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites

Fig. 2

Gut microbial composition in lung cancer patients(C) and benign diseases patients(N). (A) Heatmap showing the distribution of the microbiota composition associated with C or N group. (B) Differential taxa at the genus level analyzed by linear discriminant analysis (LDA) scores (LDA > 2.0, P < 0.05). (C) Differential taxa at the genus level analyzed by Wilcoxon rank-sum test. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us